Related Experiment Video
Updated: Aug 7, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Effect and safety of transrectal 137 CS gamma-rays in the treatment of benign prostatic hyperplasia]
Xin Li1, Ning-chen Li, Gang Wang
1Department of Urology, the First Hospital of Peking University, Institute of Urology, Peking University, Beijing 100034, China.
Objective:
To evaluate the effect and safety of transrectal 137Cs gamma-ray therapy for benign prostatic hyperplasia.
Methods:
Thirty cases of BPH were treated by transrectal 137Cs gamma-rays.
Results:
After 6 months there was significant improvement in the maximum urine flow, IPSS and QOL (P < 0.05). But no significant changes were observed in the prostate volume and residual urine (P > 0.05).
Conclusion:
Transrectal 137Cs gamma-ray therapy is safe and effective in the treatment of BPH.
